Cite
HARVARD Citation
Zhu, L. et al. (2022). A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis. EMBO molecular medicine. 14 (3), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhu, L. et al. (2022). A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis. EMBO molecular medicine. 14 (3), p. n/a. [Online].